Sanofi-Aventis Outpaces Other International Drug Players In High-speed Growth In China

SHANGHAI - Boosted by China's ever-expanding economy and ongoing health reforms, part of which are aimed at covering 90 percent of the country's 1.3 billion citizens with minimal medical insurance by 2011, drug firms posted an average sales growth rate of 27 percent in 2009, according to the global information provider IMS Health